Cargando…
Histone Deacetylases in the Inflamed Intestinal Epithelium—Promises of New Therapeutic Strategies
The intestinal epithelium is a complex, dynamic barrier that separates luminal contents from the immune compartment while mediating nutrient absorption and controlled passage of antigens to convey oral tolerance. A compromised epithelial barrier often leads to inflammation because immune cells in th...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032862/ https://www.ncbi.nlm.nih.gov/pubmed/33842512 http://dx.doi.org/10.3389/fmed.2021.655956 |
_version_ | 1783676296628273152 |
---|---|
author | Gerbeth, Lorenz Glauben, Rainer |
author_facet | Gerbeth, Lorenz Glauben, Rainer |
author_sort | Gerbeth, Lorenz |
collection | PubMed |
description | The intestinal epithelium is a complex, dynamic barrier that separates luminal contents from the immune compartment while mediating nutrient absorption and controlled passage of antigens to convey oral tolerance. A compromised epithelial barrier often leads to inflammation because immune cells in the lamina propria come into direct contact with luminal antigens. Defects in epithelial cell function were also shown to be involved in the etiology of inflammatory bowel diseases. These are severe, chronically relapsing inflammatory conditions of the gastrointestinal tract that also increase the risk of developing colorectal cancer. Despite major efforts of the scientific community, the precise causes and drivers of these conditions still remain largely obscured impeding the development of a permanent cure. Current therapeutic approaches mostly focus on alleviating symptoms by targeting immune cell signaling. The protein family of histone deacetylases (HDACs) has gained increasing attention over the last years, as HDAC inhibitors were shown to be potent tumor cell suppressors and also alleviate morbid inflammatory responses. Recent research continuously identifies new roles for specific HDACs suggesting that HDACs influence the cell signaling network from many different angles. This makes HDACs very interesting targets for therapeutic approaches but predicting effects after system manipulations can be difficult. In this review, we want to provide a comprehensive overview of current knowledge about the individual roles of HDACs in the intestinal epithelium to evaluate their therapeutic potential for inflammatory conditions of the gut. |
format | Online Article Text |
id | pubmed-8032862 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80328622021-04-10 Histone Deacetylases in the Inflamed Intestinal Epithelium—Promises of New Therapeutic Strategies Gerbeth, Lorenz Glauben, Rainer Front Med (Lausanne) Medicine The intestinal epithelium is a complex, dynamic barrier that separates luminal contents from the immune compartment while mediating nutrient absorption and controlled passage of antigens to convey oral tolerance. A compromised epithelial barrier often leads to inflammation because immune cells in the lamina propria come into direct contact with luminal antigens. Defects in epithelial cell function were also shown to be involved in the etiology of inflammatory bowel diseases. These are severe, chronically relapsing inflammatory conditions of the gastrointestinal tract that also increase the risk of developing colorectal cancer. Despite major efforts of the scientific community, the precise causes and drivers of these conditions still remain largely obscured impeding the development of a permanent cure. Current therapeutic approaches mostly focus on alleviating symptoms by targeting immune cell signaling. The protein family of histone deacetylases (HDACs) has gained increasing attention over the last years, as HDAC inhibitors were shown to be potent tumor cell suppressors and also alleviate morbid inflammatory responses. Recent research continuously identifies new roles for specific HDACs suggesting that HDACs influence the cell signaling network from many different angles. This makes HDACs very interesting targets for therapeutic approaches but predicting effects after system manipulations can be difficult. In this review, we want to provide a comprehensive overview of current knowledge about the individual roles of HDACs in the intestinal epithelium to evaluate their therapeutic potential for inflammatory conditions of the gut. Frontiers Media S.A. 2021-03-26 /pmc/articles/PMC8032862/ /pubmed/33842512 http://dx.doi.org/10.3389/fmed.2021.655956 Text en Copyright © 2021 Gerbeth and Glauben. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Gerbeth, Lorenz Glauben, Rainer Histone Deacetylases in the Inflamed Intestinal Epithelium—Promises of New Therapeutic Strategies |
title | Histone Deacetylases in the Inflamed Intestinal Epithelium—Promises of New Therapeutic Strategies |
title_full | Histone Deacetylases in the Inflamed Intestinal Epithelium—Promises of New Therapeutic Strategies |
title_fullStr | Histone Deacetylases in the Inflamed Intestinal Epithelium—Promises of New Therapeutic Strategies |
title_full_unstemmed | Histone Deacetylases in the Inflamed Intestinal Epithelium—Promises of New Therapeutic Strategies |
title_short | Histone Deacetylases in the Inflamed Intestinal Epithelium—Promises of New Therapeutic Strategies |
title_sort | histone deacetylases in the inflamed intestinal epithelium—promises of new therapeutic strategies |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8032862/ https://www.ncbi.nlm.nih.gov/pubmed/33842512 http://dx.doi.org/10.3389/fmed.2021.655956 |
work_keys_str_mv | AT gerbethlorenz histonedeacetylasesintheinflamedintestinalepitheliumpromisesofnewtherapeuticstrategies AT glaubenrainer histonedeacetylasesintheinflamedintestinalepitheliumpromisesofnewtherapeuticstrategies |